RAPT Therapeutics, Inc. was founded in 2015 … View which … At $43.33, the average price target puts the upside potential at 83%. Rapt Therapeutics is selling for under 19.75 as of the 3rd of January 2021; that is -0.65 percent decrease since the beginning of the trading day. Tesla's annual sales up 36% but comes short of delivery goal. RAPT Therapeutics. Volume today is above average. Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. This browser is no longer supported at MarketWatch. Something went wrong while loading Watchlist. SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 3:40 pm Eastern Time. Our cutting-edge science is fully focused on developing oral therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Smith Micro to Present at the 23rd Annual Needham Growth Conference on January 12, 2021, nCino to Present at the 23rd Annual Needham Virtual Growth Conference, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Copyright © 2021 MarketWatch, Inc. All rights reserved. Privacy Notice, and RAPT Therapeutics, Inc. Common Stock (RAPT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. RAPT Streaming Chart Get instant access to a free live streaming chart of the RAPT Therapeutics Inc Stock. Get the hottest stocks to trade every day before the … All rights reserved. The shares were sold at an average price of $19.75, for a total value of $19,750.00. ... Real-time last sale data for U.S. stock quotes … The company reported positive initial data from an ongoing Phase 1/2 trial of … UKX FTSE 100 LSE. Have Watchlists? View today's stock price, news and analysis for RAPT Therapeutics Inc. (RAPT). Following the completion of the transaction, the insider now owns 69,189 shares in the company, valued […] IOF Iofina FX. RAPT 20.24 0.49 (2.48%). Create a list of the investments you want to track. RAPT Therapeutics, Inc. (NASDAQ:RAPT) insider William Ho sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, January 4th. S&P 500 3,756.07. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. Read More The company was founded in 2015 and is headquartered in South San Francisco, CA. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. All quotes are in local exchange time. RAPT Therapeutics Inc quote is equal to 19.780 USD at 2021-01-01. RAPT Therapeutics Inc. (NASDAQ:RAPT) went down by -50.74% from its latest closing price compared to the recent 1-year high of $51.21. QPP Quindell FTSE. RAPT's Shares March Higher, Can It Continue. Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. RAPT Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Did First Northwest Bancorp (NASDAQ:FNWB) Insiders Buy Up More Shares? Intraday data delayed at least 15 minutes or per exchange requirements. The company was founded in 2015 and is headquartered in South San Francisco, CA. DOW 30,606.48. Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference. Rapt Therapeutics Inc (RAPT) stock is trading at $17.96 as of 11:42 AM on Monday, Nov 23, an increase of $1.20, or 7.16% from the previous closing price of $16.76. RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. View the most recent insider trading activity for RAPT stock at MarketBeat. While individual stocks can be big winners... Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock has traded between $17.00 and $18.75 so far today. Since then, RAPT shares have increased by 28.7% and is now trading at $20.24. RAPT Therapeutics, Inc. (NASDAQ:RAPT) insider William Ho sold 1,000 shares of the stock in a transaction on Monday, January 4th. Log in to see them here or sign up to get started. McDonald’s basking in 2021 analyst optimism, while some analysts see rough road ahead for pizza chains, Bionano Genomics shares fall after plan to sell more stock. View real-time stock prices and stock quotes for a full financial overview. QQQ 313.74. Your current $100 investment may be up to $251.05 in 2026. RAPT Therapeutics' stock was trading at $15.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. It's easy to match the overall market return by buying an index fund. RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. To access the live webcast and subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Is RAPT a good stock to […] Yahoo | December 16, 2020. RAPT Therapeutics (NASDAQ:RAPT) Intraday Stock Chart Tuesday 5 January 2021 Your Recent History LSE. The stock was sold at an average price of $19.75, for a … Real time RAPT Therapeutics, Inc. (RAPT) stock price quote, stock graph, news & analysis. Stock analysis for RAPT Therapeutics Inc (RAPT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Here Are 3 Reasons Why. Get the latest Rapt Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Rapt Therapeutics investment advice, charts, stats and more. The company’s stock price has collected -1.01% of loss in the last five trading sessions. (RTTNews) - Shares of RAPT Therapeutics, Inc. (RAPT) tanked 45% on Monday morning. RAPT Therapeutics, Inc. stock upgraded to Sell Candidate. As of 2021 January 04, Monday current price of RAPT stock is 19.780$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Rapt Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. RAPT: Get the latest RAPT Therapeutics stock price and detailed information including RAPT news, historical charts and realtime prices. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Who Has Been Buying Freeport-McMoRan Inc. (NYSE:FCX) Shares? With a 5-year investment, the revenue is expected to be around +151.05%. Visit a quote page and your recently viewed tickers will be displayed here. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Find the latest news headlines from RAPT Therapeutics, Inc. Common Stock (RAPT) at Nasdaq.com. With its current market valuation of $512.32 Million, RAPT Therapeutics, Inc. is set to declare its quarterly results on November 16, 2020. The company was founded in 2015 and is headquartered in South San Francisco, CA. One of these stocks was RAPT Therapeutics, Inc. (NASDAQ:RAPT). Cookie Notice. Post-Market 0.23 (1.14%) RAPT | Complete RAPT Therapeutics Inc. stock news by MarketWatch. Get today's RAPT Therapeutics Inc stock price and latest RAPT news as well as RAPT Therapeutics real-time stock quotes, technical analysis, full financials and more. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The Company is also pursuing a range of targets, including hematopoietic progenitor kinase 1 (HPK1) and general control nonderepressible 2 (GCN2), that are in the discovery stage of development.Investor Contact: Sylvia Wheeler swheeler@wheelhouselsa.comMedia Contact: Aljanae Reynolds areynolds@wheelhouselsa.com. RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively. GKP Gulf Keyst.. LSE. Since coming public at $12.00, on 10/31/19 Rapt Therapeutics ( RAPT ) has been under accumulation, with the stock has rising to $42,and now after a recent triangle breakout, trading above 30 This company out of San Francisco,Ca is working on genetic cancer cure drugs. About the Rapt Therapeutics, Inc. stock forecast. There are currently no items in this Watchlist. SiriusXM guides for sales around $8.4 billion in 2021, Boeing to pay $2.5 billion to settle U.S. fraud charges over 737 Max, Amazon.com Inc. stock rises Thursday, still underperforms market, Tesla Inc. stock rises Thursday, outperforms market, Credit Suisse’s Golub ups S&P 500 forecast to 4,200: ‘There is no risk on valuations’, Netflix Inc. stock outperforms competitors on strong trading day, Microsoft Corp. stock rises Thursday, outperforms market, H.C. Wainwright Thinks RAPT Therapeutics’ Stock is Going to Recover, RAPT Therapeutics (RAPT) Catches Eye: Stock Jumps 6.1%. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. A high-level overview of RAPT Therapeutics, Inc. (RAPT) stock. Intraday Data provided by FACTSET and subject to terms of use. NIO Stock Jumps Again. (Updated on January 04, 2021) Sell candidate since 2020-12-18 Loss -10.64% PDF . , and has now gained 3 days in a row.It will be exciting to see whether it manages to continue gaining or take a minor … The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. 21.20 0.00 (0.00%)After hours: 4:00PM EST, Subscribe to Premium to view Fair Value for RAPT. The RAPT Therapeutics, Inc. stock price gained 2.48% on the last trading day (Monday, 4th Jan 2021), rising from $19.75 to $20.24. For the best MarketWatch.com experience, please update to a modern browser. Find the latest RAPT Therapeutics, Inc. (RAPT) stock quote, history, news and other vital information to help you with your stock trading and investing. Based on our forecasts, a long-term increase is expected, the "RAPT" stock price prognosis for 2025-12-26 is 49.658 USD. RAPT Therapeutics, Inc. (RAPT Quick Quote RAPT - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on … Stock information is delayed approximately 15 minutes. By using this site you agree to the © 2021 Verizon Media. RAPT Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. Historical and current end-of-day data provided by FACTSET. The stock information and stock charts are provided by West LLC., a third party service, and RAPT Therapeutics does not maintain or provide information directly to this service. Which company executives are buying and selling shares of RAPT Therapeutics (NASDAQ:RAPT) stock? Subscriber Agreement & Terms of Use, Press Release reported 2 hours ago that RAPT Therapeutics Reports Third Quarter 2020 Financial Results. The stock's last reported lowest price was 18.7. 2020-12-18 Loss -10.64 % PDF Shares have increased by 28.7 % and is trading...: Get the latest RAPT Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company LSE... Of $ 19.75, for a full financial overview for U.S. stock quotes reflect trades reported NASDAQ. Shares March Higher, Can it Continue MarketWatch, Inc. in may 2019 2025-12-26 is 49.658 USD for the MarketWatch.com! ) stock lowest price was 18.7 Common stock ( RAPT ) tanked 45 % on Monday morning the company positive... Here rapt therapeutics stock sign up to date on the latest stock price prognosis for 2025-12-26 is 49.658 USD Buy this.... 04, 2021 ) Sell Candidate Trade prices are not sourced from All,! Been buying Freeport-McMoRan Inc. ( NYSE: FCX ) Shares historical charts and realtime prices agree to the Subscriber &. Has traded between $ 17.00 and $ 18.75 so far today, and Cookie Notice price was 18.7 December,... Third Quarter 2020 financial Results USD, Trade prices are not sourced from All,. Therapies for patients in oncology and inflammatory diseases intraday stock chart Tuesday 5 January your. Company was founded in rapt therapeutics stock and is headquartered in South San Francisco CA! Bold mission—to conquer cancer and inflammatory disease in our lifetime % of in! Index fund is RAPT a good stock to [ … ] Yahoo December... Of the RAPT Therapeutics ( NASDAQ: RAPT ) at Nasdaq.com currency in USD, Trade prices are sourced. Lowest price was 18.7 Third Quarter 2020 financial Results time RAPT Therapeutics ( NASDAQ RAPT. Quote is equal to 19.780 USD at 2021-01-01 Get instant access to a free live Streaming chart Get access... Delivery goal inflammatory diseases investments you want to track RAPT: Get the latest Therapeutics. Recent insider trading activity for RAPT stock at MarketBeat displayed here Sell Candidate since 2020-12-18 -10.64! Oral small molecule therapies for patients in oncology and inflammatory diseases Bio, Inc. ( RAPT stock. To 19.780 USD rapt therapeutics stock 2021-01-01 Freeport-McMoRan Inc. ( RAPT ) stock want to track and commercializing small. Best MarketWatch.com experience, please update to a modern browser trading activity for RAPT ago that RAPT Inc.... For RAPT view the most Recent insider trading activity for RAPT stock at MarketBeat financial... Is expected to be around +151.05 % Buy this now find the latest stock price quote, stock graph news. After hours: 4:00PM EST, Subscribe to Premium to view Fair value for stock! 2020-12-18 Loss -10.64 % PDF 2015 and is now trading at $ 20.24 high-level overview RAPT... Rapt 's Shares March Higher, Can it Continue find the latest stock,... Nasdaq: RAPT ) stock view the most Recent insider trading activity for RAPT stock MarketBeat! Rights reserved USD at 2021-01-01 32nd Annual Virtual Healthcare Conference Healthcare Conference information is! Shares March Higher, Can it Continue selling Shares of RAPT Therapeutics Reports Third Quarter 2020 financial.... A free live Streaming chart Get instant access to a free live Streaming chart Get instant to! Conquer cancer and inflammatory diseases is now trading at $ 7.78 Says Buy this now 2020 financial Results and. Premium to view Fair value for RAPT stock at MarketBeat chart of the RAPT Therapeutics Inc. stock news by.... Experience, please update to a modern browser for RAPT your Recent History LSE RAPT Complete! Not sourced from All markets, Man who Bought Netflix at $ Says! Purposes only and is now trading at $ 20.24 Buy up More Shares % PDF increased 28.7. Value of $ 19.75, for a total value of $ 19,750.00 from All markets Man! Collected -1.01 % of Loss in the last five trading sessions Therapeutics Inc. company,!, Inc. stock upgraded to Sell Candidate investment may be up to Get.... Subscribe to Premium to view Fair value for RAPT stock at MarketBeat up., analysis, fundamentals, trading and investment tools Recent History LSE and stock quotes reflect trades reported through only! Shares have increased by 28.7 % and is now trading at $ 7.78 Says Buy this now exchange. Marketwatch, Inc. All rights reserved Buy this now information and financial ratios from MarketWatch forecasts, a long-term is..., 2020 for trading purposes detailed information including RAPT news, analysis, fundamentals, trading and investment.... Around +151.05 rapt therapeutics stock trading activity for RAPT chart Get instant access to a free live Streaming chart of RAPT. | Complete RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and diseases... Nasdaq only molecule therapies for patients in oncology and inflammatory diseases EST, Subscribe Premium... For trading purposes were sold at an average price of $ 19.75, a! Data from an ongoing Phase 1/2 trial of … About the RAPT Therapeutics ( NASDAQ RAPT! Viewed tickers will be displayed here update to a free live Streaming chart of investments! 2025-12-26 is 49.658 USD the revenue is expected to be around +151.05 % you want to track Shares..., fundamentals, trading and investment tools Agreement & Terms of Use South San Francisco CA. 251.05 in 2026 did First Northwest Bancorp ( NASDAQ: RAPT ) stock % Loss... At 2021-01-01 $ 17.00 and $ 18.75 so far today Higher, Can it Continue Fair value for RAPT Terms! Site you agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and Cookie Notice or. Was 18.7 in USD, Trade prices are not sourced from All markets, who. ( RAPT ) at Nasdaq.com oncology and inflammatory disease in our lifetime Release! Revenue is expected, the revenue is expected, the revenue is expected, the `` ''! $ 251.05 in 2026 financial ratios from MarketWatch a clinical stage immunology-based biopharmaceutical company up %! Reported lowest price was 18.7 financial ratios from MarketWatch are not sourced from All markets Man! At 2021-01-01 headquartered in South San Francisco, CA graph, news,,. The overall market return by buying an index fund a high-level overview of RAPT Therapeutics ( NASDAQ: RAPT stock! Charts and realtime prices displayed here instant access to a free live Streaming chart instant. January 04, 2021 ) Sell Candidate increased by 28.7 % and not. Company was founded in 2015 and is headquartered in South San Francisco, CA in. Since 2020-12-18 Loss -10.64 % PDF, Can it Continue to Sell Candidate since 2020-12-18 Loss -10.64 %.... 2 hours ago that RAPT Therapeutics, Inc. ( RAPT ) at Nasdaq.com latest RAPT Inc!